Brief: Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results

Lineage Cell Therapeutics

11/08/2022 21:41

Aug 11 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * LINEAGE CELL - CASH, CASH EQUIVALENTS, AND MARKETABLE
SECURITIES
OF $72.0 MILLION AS OF JUNE 30, 2022 EXPECTED TO PROVIDE CAPITAL
THROUGH Q2 2024
    * QTRLY LOSS PER SHARE $0.04
    * Q2 EARNINGS PER SHARE VIEW $-0.04 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw5nG7xNa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))